These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 7666054

  • 1. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W, Harrington CR, Wischik CM, Hauser DL, Roth M.
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease.
    Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M.
    J Neuropathol Exp Neurol; 1994 Mar; 53(2):158-64. PubMed ID: 7509849
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K, Alonso AC, Gong CX, Khatoon S, Pei JJ, Wang JZ, Grundke-Iqbal I.
    J Neural Transm Suppl; 1998 Mar; 53():169-80. PubMed ID: 9700655
    [Abstract] [Full Text] [Related]

  • 4. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC, Schneider A, Mandelkow EM, Hyman BT.
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [Abstract] [Full Text] [Related]

  • 5. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K, Grundke-Iqbal I.
    Mol Neurobiol; 1991 Jan; 5(2-4):399-410. PubMed ID: 1726645
    [Abstract] [Full Text] [Related]

  • 6. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.
    Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H.
    Brain Res; 1993 Jan 22; 601(1-2):164-72. PubMed ID: 8431763
    [Abstract] [Full Text] [Related]

  • 7. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
    Wang JZ, Xia YY, Grundke-Iqbal I, Iqbal K.
    J Alzheimers Dis; 2013 Jan 22; 33 Suppl 1():S123-39. PubMed ID: 22710920
    [Abstract] [Full Text] [Related]

  • 8. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ, Grundke-Iqbal I, Iqbal K.
    Eur J Neurosci; 2007 Jan 22; 25(1):59-68. PubMed ID: 17241267
    [Abstract] [Full Text] [Related]

  • 9. Molecular dissection of the neurofibrillary lesions of Alzheimer's disease.
    Goedert M.
    Arzneimittelforschung; 1995 Mar 22; 45(3A):403-9. PubMed ID: 7763334
    [Abstract] [Full Text] [Related]

  • 10. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease.
    Luna-Muñoz J, Chávez-Macías L, García-Sierra F, Mena R.
    J Alzheimers Dis; 2007 Dec 22; 12(4):365-75. PubMed ID: 18198423
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM.
    Biochemistry; 1999 Mar 23; 38(12):3549-58. PubMed ID: 10090741
    [Abstract] [Full Text] [Related]

  • 12. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP.
    Bull Mem Acad R Med Belg; 1999 Mar 23; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [Abstract] [Full Text] [Related]

  • 13. Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments.
    Kimura T, Ono T, Takamatsu J, Yamamoto H, Ikegami K, Kondo A, Hasegawa M, Ihara Y, Miyamoto E, Miyakawa T.
    Dementia; 1996 Mar 23; 7(4):177-81. PubMed ID: 8835879
    [Abstract] [Full Text] [Related]

  • 14. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM, Vandré DD.
    J Neurochem; 1996 Dec 23; 67(6):2405-16. PubMed ID: 8931473
    [Abstract] [Full Text] [Related]

  • 15. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
    Iqbal K, Grundke-Iqbal I.
    J Alzheimers Dis; 2006 Dec 23; 9(3 Suppl):219-42. PubMed ID: 16914861
    [Abstract] [Full Text] [Related]

  • 16. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules.
    Alonso AC, Grundke-Iqbal I, Iqbal K.
    Nat Med; 1996 Jul 23; 2(7):783-7. PubMed ID: 8673924
    [Abstract] [Full Text] [Related]

  • 17. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
    Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P.
    J Neurochem; 2003 Aug 23; 86(3):582-90. PubMed ID: 12859672
    [Abstract] [Full Text] [Related]

  • 18. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
    Iqbal K, Alonso Adel C, El-Akkad E, Gong CX, Haque N, Khatoon S, Pei JJ, Tsujio I, Wang JZ, Grundke-Iqbal I.
    J Mol Neurosci; 2002 Aug 23; 19(1-2):95-9. PubMed ID: 12212801
    [Abstract] [Full Text] [Related]

  • 19. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Barrachina M, Puig B.
    Acta Neuropathol; 2002 Dec 23; 104(6):583-91. PubMed ID: 12410379
    [Abstract] [Full Text] [Related]

  • 20. Truncated tau protein as a new marker for Alzheimer's disease.
    Novák M.
    Acta Virol; 1994 Jun 23; 38(3):173-89. PubMed ID: 7817900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.